FDA.reportPublic FDA data

Symproic 0.2 MG Oral Tablet

RxCUI
1876609
RxNorm name
Symproic 0.2 MG Oral Tablet
Display name
Symproic 0.2 MG Oral Tablet
Full name
Symproic 0.2 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:16

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SYMPROICNALDEMEDINEBioDelivery Sciences International Incb1a1256c-a1eb-4abe-ab1e-30e4711afd162025-07-25Warnings, Adverse reactionsExact identifier
rxcui: 1876609

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
b1a1256c-a1eb-4abe-ab1e-30e4711afd16Symproic 0.2 MG Oral Tablet [PSN] · naldemedine 0.2 MG Oral Tablet [Symproic] [SBD] · Symproic 0.2 MG Oral Tablet [SY]310These highlights do not include all the information needed to use SYMPROIC safely and effectively. See full prescribing information for SYMPROIC. SYMPROIC ® (naldemedine tablets for oral use) Initial U.S. Approval: 201720250725